Cadila Of India Sued By Shire Of Ireland Over U.S. Bowel Drug Patent
This article was originally published in PharmAsia News
Executive SummaryIndia's Cadila Healthcare has been sued in a U.S. court by Shire, an Ireland-based drug maker, to block a generic version of the Shire medicine Lialda (mesalamine) for treating bowel disorder
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.